Gradual discontinuation may reduce rebound effects compared to abrupt cessation
12 mg weekly drove the most dramatic outcomes, with participants achieving up to 24% body weight reduction at 48 weeks a figure exceeding results from current FDA-approved GLP-1 or GIP agonists Pasqualotto, Eric, et al
This combined mechanism could potentially lead to more significant feelings of fullness and less food chatter, enhancing its overall effectiveness
Orandi , MD, PhD, associate professor in the departments of surgery and medicine at NYU Grossman School of Medicine and NYU Langone Health, and colleagues analyzed data from 18,016 U.S
By targeting two pathways instead of one, tirzepatide may provide another effective option for eligible patients
If you suspect a poisoning, call the national poison control helpline at 1-800-222-1222 to be connected with experts at the nearest regional center